'Smoker's paradox' in young patients with acute myocardial infarction

Clinical and Experimental Pharmacology and Physiology

Volumn 39, Issue 7, 2012, Pages 630-635

  Chen, Kang Yin ^a,b   Rha, Seung Woon ^a,g   Li, Yong Jian ^c   Jin, Zhe ^c   Minami, Yoshiyasu ^d   Park, Ji Young ^a   Poddar, Kanhaiya L ^a   Ramasamy, Sureshkumar ^a   Wang, Lin ^b,e   Li, Guang Ping ^b   Choi, Cheol Ung ^a   Oh, Dong Joo ^a   Jeong, Myung Ho ^f,g   Kim, Young Jo ^g   Kim, Chong Jin ^g   Cho, Myeong Chan ^g   Ahn, Young Keun ^g   Kim, Jong Hyun ^g   Chae, Shung Chull ^g   Hur, Seung Ho ^g   Seong, In Whan ^g   Hong, Taek Jong ^g   Choi, Dong Hoon ^g   Chae, Jei Keon ^g   Rhew, Jae Young ^g   Kim, Doo Il ^g   Chae, In Ho ^g   Yoon, Jung Han ^g   Koo, Bon Kwon ^g   Kim, Byung Ok ^g   Lee, Myoung Yong ^g   Kim, Kee Sik ^g   Hwang, Jin Yong ^g   Oh, Seok Kyu ^g   Lee, Nae Hee ^g   Jeong, Kyoung Tae ^g   Tahk, Seung Jea ^g   Bae, Jang Ho ^g   Park, Keum Soo ^g   Han, Kyoo Rok ^g   Ahn, Tae Hoon ^g   Kim, Moo Hyun ^g   Yang, Ju Young ^g   Rhim, Chong Yun ^g   Gwon, Hyeon Cheol ^g   Park, Seong Wook ^g   Koh, Young Youp ^g   Joo, Seung Jae ^g   Kim, Soo Joong ^g   Jin, Dong Kyu ^g   Cho, Jin Man ^g   Cho, Jeong Gwan ^g   Chung, Wook Sung ^g   Jang, Yang Soo ^g   Seung, Ki Bae ^g   Jung, Seung Park ^g   more..

^a Korea University College of Medicine   (South Korea)

^b SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

^c Tianjin Naikai Hospital   (China)

^d SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

^e Tianjin Chest Hospital   (China)

^f Chonnam National University Medical School   (South Korea)

^g NONE

Author keywords

Acute myocardial infarction; Smoker's paradox; Young patients

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIAC PATIENT; CONTROLLED STUDY; DEATH; FEMALE; GENDER; HEART DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84862848543     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2012.05721.x     Document Type: Article

References (25)

1. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and Other Societies on coronary prevention. Atherosclerosis 1998; 140: 199-270.
2. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 1999; 100: 1481-92.
3. Scott WC, Bernstein SL, Coble YD, et al. The worldwide smoking epidemic. Tobacco trade, use, and control. Council on Scientific Affairs. JAMA 1990; 263: 3312-8.
4. Bartecchi CE, MacKenzie TD, Schrier RW. The human costs of tobacco use (1). N. Engl. J. Med. 1994; 330: 907-12.
5. MacKenzie TD, Bartecchi CE, Schrier RW. The human costs of tobacco use (2). N. Engl. J. Med. 1994; 330: 975-80.
6. Barbash GI, White HD, Modan M et al. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation 1993; 87: 53-8.
7. Zahger D, Cercek B, Cannon CP et al. How do smokers differ from nonsmokers in their response to thrombolysis? (The TIMI-4 trial.) Am. J. Cardiol. 1995; 75: 232-6.
8. Ishihara M, Sato H, Tateishi H et al. Clinical implications of cigarette smoking in acute myocardial infarction: Acute angiographic findings and long-term prognosis. Am. Heart J. 1997; 134: 955-60.
9. Barbash GI, Reiner J, White HD et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: Mechanism of the 'smoker's paradox' from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. J. Am. Coll. Cardiol. 1995; 26: 1222-9.
10. Andrikopoulos GK, Richter DJ, Dilaveris PE et al. In-hospital mortality of habitual cigarette smokers after acute myocardial infarction: The 'smoker's paradox' in a countrywide study. Eur. Heart J. 2001; 22: 776-84.
11. Himbert D, Klutman M, Steg G, White K, Gulba DC. Cigarette smoking and acute coronary syndromes: A multinational observational study. Int. J. Cardiol. 2005; 100: 109-17.
12. Gottlieb S, Boyko V, Zahger D et al. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey). J. Am. Coll. Cardiol. 1996; 28: 1506-13.
13. Weisz G, Cox DA, Garcia E et al. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction: The smoker's paradox revisited. Am. Heart J. 2005; 150: 358-64.
14. Ruiz-Bailen M, de Hoyos EA, Reina-Toral A, Torres-Ruiz JM, Alvarez-Bueno M, Gomez Jimenez FJ. Paradoxical effect of smoking in the Spanish population with acute myocardial infarction or unstable angina: Results of the ARIAM Register. Chest 2004; 125: 831-40.
15. Chen KY, Rha SW, Li YJ et al. Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Circulation 2009; 119: 3207-14.
16. Li YJ, Rha SW, Chen KY et al. Clinical characteristics and mid-term outcomes of acute myocardial infarction patients with prior cerebrovascular disease in an Asian population: Lessons from the Korea Acute Myocardial Infarction Registry. Clin. Exp. Pharmacol. Physiol. 2010; 37: 581-6.
17. Zahger D, Shah PK. Effect of smoking status on response to thrombolytic therapy. J. Am. Coll. Cardiol. 1996; 28: 283.
18. Andrikopoulos GK, Chimonas ET, Toutouzas PK. Paradoxical clinical value of another smoker's paradox. Circulation 2002; 105: e55.
19. Park KW, Park JJ, Jeon KH et al. Enhanced clopidogrel responsiveness in smokers: Smokers' paradox is dependent on cytochrome P450 CYP1A2 status. Arterioscler. Thromb. Vasc. Biol. 2011; 31: 665-71.
20. Berger JS, Bhatt DL, Steinhubl SR et al. Smoking, clopidogrel, and mortality in patients with established cardiovascular disease. Circulation 2009; 120: 2337-44.
21. Desai NR, Mega JL, Jiang S, Cannon CP, Sabatine MS. Interaction between cigarette smoking and clinical benefit of clopidogrel. J. Am. Coll. Cardiol. 2009; 53: 1273-8.
22. Hasdai D, Garratt KN, Grill DE, Lerman A, Holmes DR Jr. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N. Engl. J. Med. 1997; 336: 755-61.
23. Cohen DJ, Doucet M, Cutlip DE, Ho KK, Popma JJ, Kuntz RE. Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: Another smoker's paradox? Circulation 2001; 104: 773-8.
24. Galan KM, Deligonul U, Kern MJ, Chaitman BR, Vandormael MG. Increased frequency of restenosis in patients continuing to smoke cigarettes after percutaneous transluminal coronary angioplasty. Am. J. Cardiol. 1988; 61: 260-3.
25. Violaris AG, Thury A, Regar E, Melkert R, Serruys PW. Influence of a history of smoking on short term (six month) clinical and angiographic outcome after successful coronary angioplasty. Heart 2000; 84: 299-306.